Notch2′ high mRNA expression was found to be significantly correlated to worsen OS for all gastric cancer patients, HR 1.58 (1.31–1.89), p = 6.5e-07 (Fig. 2A), as well as in intestinal type cancer patients, HR 2.36 (1.72–3.25), p = 5.3e-08 (Fig. 2B), and in diffuse type cancer patients, HR 1.62 (1.15–2.28), p = 0.0051 (Fig. 2C). This evidence concerns the gene NOTCH2 and gastric cancer.